NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»25/11/2009 [Company watch]
China Nuokang Bio-Pharma Plans a Nasdaq IPO

China Nuokang Bio-Pharmaceutical, Inc., a Chinese drug company focused on hematological and cardiovascular products, has filed for a $69 million IPO of American Depository Shares (ADSs).

 

China Nuokang Bio-Pharmaceutical, Inc., a Chinese drug company focused on hematological and cardiovascular products, has filed for a $69 million IPO of American Depository Shares (ADSs).

 

China Nuokang plans to issue 4,526,979 ADSs and the selling will offer 473,021 ADSs, at a price between $10 and $12 per ADS. Each ADS represents eight ordinary shares of China Nuokang Bio-Pharmaceutical\'s share capital.

The selling shareholders have granted the underwriters the right to purchase up to 750,000 additional ADSs to cover over-allotments. The company plans to trade on the NASDAQ Global Market under the ticker symbol \'NKBP.\' Anglo China Bio-technology Investment Holdings Limited, Sequoia Capital China Growth Fund I., L.P., Britain Ukan Technology Investment Holdings (Group) Limited and HBM BioMed China, and other directors and employees include Baizhong Xue, Neil Nanpeng Shen are selling their stake in China Nuokang through the IPO.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.